COVID-19 SIG

Purpose

To provide a forum fr sharing experiences of statistical and methodological issues relating to clinical trials impacted by COVID-19, clinical trials investigating new treatments for COVID-19 and diagnostic/antibody tests for COVID-19.

Objectives

 

Who we are

Name Company/Institution
James Bell BI
Lars Endahl Novo Nordisk
Chrissie Fletcher (Co-Chair)GSK
Christine Hicking Merck
Achim Guettner Novartis
Khadija Rantell MHRA
Andrea Schulze Bayer
Tri Tat CROS NT
Marcel Wolbers Roche
David Wright (Co-Chair)AstraZeneca

How can you become involved with the SIG?

If you would like to become an active member of the COVID-19 SIG and drive forward it’s activities, please send an email to Chrissie.



EFSPI_Logo

Upcoming Events

Latest Jobs